Oxford Bioscience Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 225

  • Portfolio
  • 5

  • Exits
  • 128

Exits

Oxford Bioscience Partners General Information

Company Description

Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts. The firm invested in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. Oxford invested in pre-commercial stage businesses that solve problems throughout the international life science market.

Business Details

Website
www.oxbio.com
Year Founded
1992
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • P.O. Box 207
  • 12 Giles Place
  • Mansfield, MA 02048
  • United States

Oxford Bioscience Partners Investments (225)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Yolia Health 01-Jan-2017 Later Stage VC 000 Therapeutic Devices Generating Revenue 00000000 000
GreenLight Biosciences 15-Jun-2015 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable 00000000 000
CardioFocus 05-Jan-2015 00000 00000 000.00 Surgical Devices Generating Revenue
eSionic 19-Nov-2014 00000 00000 Energy Storage Out of Business 0000000 0000
Phyto (Food Products) 28-Apr-2014 00000 00000 Food Products Generating Revenue
Affinium Pharmaceuticals 30-Aug-2013 00000 00000 000.00 Pharmaceuticals Out of Business 0000 000000
CJ Bioscience 01-Aug-2013 00000 00000 00.000 Biotechnology Generating Revenue
Dicerna Pharmaceuticals 01-Aug-2013 00000 00000 0000 Pharmaceuticals Generating Revenue 0000000 0000
Luca Technologies 17-Jan-2013 Later Stage VC 000 Energy Production Out of Business 0000000 0000
PharmAbcine 11-Jun-2012 Early Stage VC 00.00 Biotechnology Generating Revenue
You’re viewing 10 of 225 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Bioscience Partners Exits (128)

Company Name Exit Date Exit Type Exit Size
abiliti 02-Sep-2022 Out of Business
GreenLight Biosciences 04-Feb-2022 0000000 0000 00000
Adastra Pharmaceuticals 07-Sep-2021 000000000000
Melinta Therapeutics 27-Dec-2019 0000000000:
Mitralign 12-Mar-2019 000000000000
PharmAbcine 21-Nov-2018 000
Ensemble Therapeutics 22-Nov-2017 000 00 00000
Melinta Therapeutics 03-Nov-2017 0000000 0000
Selventa 30-Jun-2017 Out of Business
Glori Energy 24-Mar-2017 Merger/Acquisition
You’re viewing 10 of 128 exits. Get the full list »

Oxford Bioscience Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Oxford Bioscience Partners‘s full profile, request access.

Request a free trial

Oxford Bioscience Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Oxford Bioscience Partners Management, Team & Partners (27)

Name Title Deals Funds Boards Office
Daniel Cole Venture Partner 00 0 0 Boston, MA
You’re viewing 1 of 27 team members. Get the full list »

Oxford Bioscience Partners FAQs

  • What is Oxford Bioscience Partners?

    Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts.

  • When was Oxford Bioscience Partners founded?

    Oxford Bioscience Partners was founded in 1992.

  • Who is the founder of Oxford Bioscience Partners?

    Cornelius Ryan is the founder of Oxford Bioscience Partners.

  • Where is Oxford Bioscience Partners headquartered?

    Oxford Bioscience Partners is headquartered in Mansfield, MA.

  • How many investments has Oxford Bioscience Partners made?

    Oxford Bioscience Partners has made 225 investments.

  • What has Oxford Bioscience Partners invested in?

    Oxford Bioscience Partners has made numerous investments in companies like Yolia Health, GreenLight Biosciences, and CardioFocus within the Therapeutic Devices, Biotechnology, and Surgical Devices industries.

  • What has Oxford Bioscience Partners invested in recently?

    Oxford Bioscience Partners's latest investment was on 01-Jan-2017 in Yolia Health, a company within the Therapeutic Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »